Загрузка...

P08.33 GLIOSTRY (Glioblastoma Registry) of the AINO (Italian Association of Neuro-Oncology): final analysis of factors influencing survival in glioblastoma patients receiving the nitrosourea fotemustine at first progression following chemoradiation.

BACKGROUND: Patients with glioblastoma at first progression after standard radiotherapy and temozolomide (TMZ) often receive nitrosoureas, but factors influencing survival following these drugs are not well known. The aim of this retrospective study was to investigate the factors influencing progres...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Neuro Oncol
Главные авторы: Rudà, R., Lombardi, G., Scoccianti, S., Pasqualetti, F., Silvani, A., Pace, A., Arcicasa, M., Salvati, M., Caroli, M., Soffietti, R.
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2016
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5782662/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now188.166
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!